Pieternella J Lugtenburg

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. doi request reprint Impact of age group on febrile neutropenia risk assessment and management in patients with diffuse large B-cell lymphoma treated with R-CHOP regimens
    Pieternella Lugtenburg
    Department of Hematology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
    Clin Lymphoma Myeloma Leuk 12:297-305. 2012
  2. pmc Management of aplastic anemia in a woman during pregnancy: a case report
    Krista Jm Stibbe
    Department of Obstetrics of Gynaecology, Erasmus University Medical Center, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    J Med Case Reports 5:66. 2011
  3. ncbi request reprint Treatment of diffuse large B-cell lymphoma in the elderly: strategies integrating oncogeriatric themes
    Pieternella J Lugtenburg
    Department of Hematology, Erasmus MC, University Medical Center, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    Curr Oncol Rep 10:412-9. 2008
  4. doi request reprint Three-day treatment with imipenem for unexplained fever during prolonged neutropaenia in haematology patients receiving fluoroquinolone and fluconazole prophylaxis: a prospective observational safety study
    Lennert Slobbe
    Department of Internal Medicine, Division of Infectious Diseases, s Gravendijkwal 230, Erasmus MC, Rotterdam, The Netherlands
    Eur J Cancer 45:2810-7. 2009
  5. doi request reprint Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study
    Lennert Slobbe
    Department of Internal Medicine, Division of Infectious Diseases, Erasmus Medical Centre, Rotterdam, The Netherlands
    Clin Infect Dis 47:1507-12. 2008
  6. pmc Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial
    Lennert Slobbe
    Department of Internal Medicine, Division of Infectious Diseases and Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Center, Rotterdam, The Netherlands
    PLoS ONE 5:e10840. 2010
  7. ncbi request reprint Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial
    Edo Vellenga
    Department of Hematology, University Medical Center, Groningen, The Netherlands
    Blood 111:537-43. 2008
  8. doi request reprint Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial
    Bart J Rijnders
    Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
    Clin Infect Dis 46:1401-8. 2008
  9. ncbi request reprint Incidence of voriconazole hepatotoxicity during intravenous and oral treatment for invasive fungal infections
    Jan G den Hollander
    Department of Internal Medicine, MCRZ, Rotterdam, The Netherlands
    J Antimicrob Chemother 57:1248-50. 2006

Collaborators

Detail Information

Publications9

  1. doi request reprint Impact of age group on febrile neutropenia risk assessment and management in patients with diffuse large B-cell lymphoma treated with R-CHOP regimens
    Pieternella Lugtenburg
    Department of Hematology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
    Clin Lymphoma Myeloma Leuk 12:297-305. 2012
    ..Better application of guidelines could reduce rates of FN and improve outcomes...
  2. pmc Management of aplastic anemia in a woman during pregnancy: a case report
    Krista Jm Stibbe
    Department of Obstetrics of Gynaecology, Erasmus University Medical Center, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    J Med Case Reports 5:66. 2011
    ..abstract:..
  3. ncbi request reprint Treatment of diffuse large B-cell lymphoma in the elderly: strategies integrating oncogeriatric themes
    Pieternella J Lugtenburg
    Department of Hematology, Erasmus MC, University Medical Center, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    Curr Oncol Rep 10:412-9. 2008
    ..This article reviews the efficacy and toxicity of the current treatment regimens applied for the treatment of diffuse large B-cell lymphoma in elderly patients and provides practical recommendations for the management of these patients...
  4. doi request reprint Three-day treatment with imipenem for unexplained fever during prolonged neutropaenia in haematology patients receiving fluoroquinolone and fluconazole prophylaxis: a prospective observational safety study
    Lennert Slobbe
    Department of Internal Medicine, Division of Infectious Diseases, s Gravendijkwal 230, Erasmus MC, Rotterdam, The Netherlands
    Eur J Cancer 45:2810-7. 2009
    ..This study evaluates the safety of discontinuing empirical broad-spectrum antibiotics if no microbial source is documented after an initial work-up of 72 h...
  5. doi request reprint Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study
    Lennert Slobbe
    Department of Internal Medicine, Division of Infectious Diseases, Erasmus Medical Centre, Rotterdam, The Netherlands
    Clin Infect Dis 47:1507-12. 2008
    ..Management of IA is expensive, which makes prevention desirable. Because hospital resources are limited, prevention costs have to be compared with treatment costs and outcome...
  6. pmc Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial
    Lennert Slobbe
    Department of Internal Medicine, Division of Infectious Diseases and Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Center, Rotterdam, The Netherlands
    PLoS ONE 5:e10840. 2010
    ..In this randomized, double-blind, placebo-controlled trial, we studied the efficacy and safety of a daily ethanol lock for the prevention of CRBSI in patients with a tunnelled central venous catheter (CVC)...
  7. ncbi request reprint Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial
    Edo Vellenga
    Department of Hematology, University Medical Center, Groningen, The Netherlands
    Blood 111:537-43. 2008
    ..These results demonstrate improved FFS and PFS for relapsed aggressive B-cell NHL if rituximab is added to the re-induction chemotherapy regimen...
  8. doi request reprint Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial
    Bart J Rijnders
    Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
    Clin Infect Dis 46:1401-8. 2008
    ..Because pulmonary deposition of conidia is the first step in developing IPA, we hypothesized that inhalation of liposomal amphotericin B would prevent IPA...
  9. ncbi request reprint Incidence of voriconazole hepatotoxicity during intravenous and oral treatment for invasive fungal infections
    Jan G den Hollander
    Department of Internal Medicine, MCRZ, Rotterdam, The Netherlands
    J Antimicrob Chemother 57:1248-50. 2006
    ..The aim of this study was to compare the incidence of hepatotoxicity in patients treated with the oral formulation of voriconazole with that in patients treated with the iv formulation...